Subscribe to our Newsletters !!

    Kumar Jeetendra

    US affirms restart of Johnson and Johnson jabs, say controllers

    Johnson & Johnson’s COVID-19 vaccinations can restart, United States health regulators said on April 23, after the shots’ rollout was paused due to worries over blood clotting. Health authorities in the US April 14 proposed a halt on the vaccine following instances of severe blood clots among a handful of the millions of Americans who

    Study reveals insight into the capacity of CBD to decrease pain

    It’s been hailed as a wonder drug and it’s certainly creating wonder profits. By some estimates, the Cannabidiol (or CBD) market could be worth $20 billion dollars by 2024. While consumers tout its effectiveness in pain relief, up until now there has been limited experimental human research on the true effectiveness of the medication. But

    New stage helps non-specialists use AI to examine microscopy pictures

    A new, publicly available platform helps non-experts utilize artificial intelligence to examine microscopy images. The platform has been developed at Åbo Akademi University in Finland and Instituto Gulbenkian de Ciência, Portugal, and will be of big help in research and diagnostics using modern day microscopes. Software using artificial intelligence, AI, is revolutionizing how microscopy images

    NIAID sets up a clinical research organization to improve comprehension of child asthma

    This nationwide network will conduct observational studies and clinical trials to improve understanding of asthma and develop prevention and treatment approaches tailored to children of low-income families residing in urban communities. NIAID plans to provide approximately $70 million over seven years to support the CAUSE network. This new initiative expands and extends NIAID’s long-standing attempts

    Moderna vaccine being surveyed for WHO emergency listing: WHO representative

    Moderna’s COVID-19 vaccine is being reviewed on Monday by technical experts for possible WHO emergency use listing, a World Health Organization spokesman told Reuters. “Moderna is being reviewed at the TAG (technical advisory group) meeting today,” WHO spokesman Christian Lindmeier said in reply to a query. A decision on the US drugmaker’s vaccine was expected

    Researchers examine how oxygen radicals secure against cancer

    Initially, oxygen radicals – reactive oxygen species, or ROS for short – were thought of as exclusively harmful in the body. They’re produced, by way of example, by smoking or UV radiation. Because of their high reactivity, they could damage many important molecules in cells, including the hereditary molecule DNA. As a result, there’s a

    NDA Group announces Christine Lind as the new VP of Commercial

    Sweden – April 27, 2021 –Christine Lind, joins NDA Group as Vice President of Commercial from her most recent role as Strategy and Business Development advisor to BioArctic AB. With over 20 years’ experience in a variety of roles within the Life Science sector, Christine’s track record of both team leadership and successful commercial transactions

    Upturn in Demand for High Performance Mini Turbine Flowmeters

    Titan Enterprises, a leading manufacturer and supplier of affordable, precision liquid flow measurement devices for a wide range of applications, reports an upturn in sales within its low flow mini turbine flowmeter range. Small turbine flow meters are adaptable liquid flow devices that Titan has successfully employed in batching processes and dispensing applications particularly within

    New Polishing Technique Improves Finesse of Fabry Perot Etalons

    Optical Surfaces Ltd. reports on the development of a new polishing technique that has been shown to reproducibly improve the spectral filtering capability (finesse) of Fabry Perot etalons. For over two decades – Optical Surfaces has supplied precisely matched Fabry-Perot etalon pairs to Table Stable Ltd. (Mettmenstetten, Switzerland) for use as a key component in

    Cipla enters into a licensing agreement with MSD to expand access to investigational oral therapeutic drug for COVID-19 treatment

    Mumbai, India; April 28, 2021: Cipla Limited (BSE: 500087; NSE: CIPLA EQ; and hereafter referred to as “Cipla”) today announced that it has signed a non-exclusive licensing agreement with MSD a tradename of Merck & Co., Inc. Kenilworth, NJ., USA for the manufacturing and distribution of Molnupiravir, the investigational oral antiviral drug currently being studied

    Novel platform has potential to detect many disease-related biomarkers in just one test

    Most conventional molecular diagnostics usually detect only one disease-related biomarker. Fantastic examples are the PCR tests now used to diagnose COVID-19 by detecting a particular sequence from SARS-CoV-2. Such so-called singleplex methods give reliable results because they are”calibrated” to a single biomarker. However, determining whether a patient is infected with a new SARS-CoV-2 version or